| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.47B | $4.99B | $4.29B |
| YoY Revenue Growth % | +9.8% | +16.3% | — |
| Gross Profit | $3.16B | $2.89B | — |
| Gross Margin % | 57.7% | 57.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.26B | $1.18B | $927.5M |
| Operating Margin % | 23.1% | 23.6% | 21.6% |
| Net Income (GAAP) | $1.02B | $966.1M | $759.6M |
| EBITDA (Normalized) | $1.33B | $1.25B | $1.08B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.18B | $1.04B | $1.03B |
| Capital Expenditures (CapEx) | $84.6M | $86.2M | $192.9M |
| Free Cash Flow (FCF) | $1.10B | $958.4M | $840.2M |
| FCF Margin % | 20.1% | 19.2% | 19.6% |
| Return on Invested Capital (ROIC %) | 67.3% | 70.7% | 19.5% |
| Cash & Short-Term Equivalents | $2.09B | $2.24B | — |
| Total Debt (Short + Long Term) | $959.9M | $927.7M | $1.45B |
| Total Stockholders' Equity | $2.61B | $2.63B | $2.98B |